We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Elan Targeted In Off-Label Marketing Probe

Law360 (March 5, 2007, 12:00 AM EST) -- Irish pharmaceutical company Elan Corp. is facing a kickback probe from the U.S. Department of Justice and the Department of Health over the promotion of epilepsy drug Zonegran for off-label uses....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.